|
NIPA2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.380300E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.472000E-02 |
| Normal-vs-Stage2 |
3.691400E-01 |
| Normal-vs-Stage3 |
1.348230E-01 |
| Normal-vs-Stage4 |
8.052000E-01 |
| Stage1-vs-Stage2 |
8.780800E-01 |
| Stage1-vs-Stage3 |
9.261400E-01 |
| Stage1-vs-Stage4 |
5.810600E-01 |
| Stage2-vs-Stage3 |
8.290400E-01 |
| Stage2-vs-Stage4 |
7.050000E-01 |
| Stage3-vs-Stage4 |
5.214600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.846300E-02 |
| Normal-vs-AfricanAmerican |
4.922600E-01 |
| Normal-vs-Asian |
6.160400E-01 |
| Caucasian-vs-AfricanAmerican |
4.209400E-01 |
| Caucasian-vs-Asian |
9.710600E-01 |
| AfricanAmerican-vs-Asian |
7.505200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.540500E-02 |
| Normal-vs-Female |
9.150200E-01 |
| Male-vs-Female |
2.794500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.351500E-02 |
| Normal-vs-Extreme_Weight |
3.520400E-02 |
| Normal-vs-Obese |
5.507600E-01 |
| Normal-vs-Extreme_Obese |
2.169600E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.916800E-01 |
| Normal_Weight-vs-Obese |
2.785800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.611600E-01 |
| Extreme_Weight-vs-Obese |
2.103200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.731000E-01 |
| Obese-vs-Extreme_Obese |
3.258600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.297400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.281000E-01 |
| Normal-vs-Age(61-80Yrs) |
4.695900E-02 |
| Normal-vs-Age(81-100Yrs) |
6.677200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.374200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.303900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.777600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.910200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.668200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.260600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.178400E-01 |
| Normal-VS-Type2 PRCC |
3.396200E-02 |
| Normal-VS-KIRP CIMP |
3.318800E-01 |
| Normal-VS-Unclassified PRCC |
3.328800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.170800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.413200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.979000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.595600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.513200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.164000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.903600E-03 |
| Normal-vs-N1 |
3.342000E-01 |
| Normal-vs-N2 |
7.899600E-01 |
| N0-vs-N1 |
1.770840E-01 |
| N0-vs-N2 |
4.850800E-01 |
| N1-vs-N2 |
9.722600E-01 |
|
|
